checkAd
    Startseite > Aktien > scPharmaceuticals > Nachrichten
    scPharmaceuticals Aktie
    4,1800
     
    EUR
    -2,34 %
    -0,1000 EUR
    Letzter Kurs 30.04.24 Tradegate
    4,2200
     
    EUR
    1.189 STK
    Geldkurs 11:12:01
    4,2600
     
    EUR
    1.172 STK
    Briefkurs 11:12:01
    ISIN: US8106481059 · WKN: A2H7XD · SYM: 2SX · USA

    Neueste Nachrichten

    scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
    24.04.24 · globenewswire · scPharmaceuticals
    scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
    13.03.24 · globenewswire · scPharmaceuticals
    scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024
    06.03.24 · globenewswire · scPharmaceuticals
    scPharmaceuticals to Participate in Two Upcoming Investor Conferences
    28.02.24 · globenewswire · scPharmaceuticals
    Hohe Leerverkaufsquote: Die 10 meistgehassten Aktien der Wall Street: Ist Ihre dabei?
    09.01.24 · wallstreetONLINE NewsUpdate · Cutera
    Hohe Leerverkaufsquote: Das sind die zehn meistgehassten Aktien an der Wall Street
    09.01.24 · wallstreetONLINE Redaktion · Cutera
    scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX Revenue
    04.01.24 · globenewswire · scPharmaceuticals
    scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
    08.11.23 · globenewswire · scPharmaceuticals
    scPharmaceuticals to Participate in Two Upcoming Investor Conferences
    31.10.23 · globenewswire · scPharmaceuticals
    scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    05.10.23 · globenewswire · scPharmaceuticals
    scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives
    19.09.23 · globenewswire · scPharmaceuticals
    scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
    05.09.23 · globenewswire · scPharmaceuticals